Damiano de Felice chairs panel at US SIF Annual Conference
Thursday, 11 May 2017
On Thursday 11 May, Damiano de Felice will moderate the panel ‘Access to Medicine: A Material Issue for Investors in Pharmaceutical Companies’ at the 2017 US SIF Annual Conference in Chicago. The members of the panel will discuss how the affordability and accessibility of medicines enhance shareholder value and are good for business. It will also look at investor engagement on pricing and access.
- Lauren Compere – Managing Director at Boston Common Asset Management,
- Marshall Gordon – Senior Research Analyst covering the health care sector and Portfolio Manager of the ClearBridge Global Health Care Innovations Strategy – and
- Benjamin Tiede – Strategy and Project Management lead for the Global Public Health (GPH) group of Johnson & Johnson.
US SIF is a leading forum for sustainable and responsible investment in the US. It also addresses impact investing, focusing on investments with a social return.